Abstract Synchrotron radiation has great potential to improve cancer radiotherapy, a major cancer treatment received by about 50% cancer patients annually. A new synchrotron-based modality, microbeam radiotherapy (MRT), has shown promise for cancer treatment. MRT utilizes high intensity X-rays collimated to planar microbeams 25 μm-wide and with 200 μm period. MRT effectively ablates tumours but causes less damage to normal tissues compared to conventional broadbeam (BB) radiotherapy techniques. Little is known about the mechanisms underlying this remarkable result. We initiated a study of systemic (“abscopal”, “distant bystander”) effects1,2 of MRT and BB irradiation in C57BL/6J mice. Skin areas (2x2 and 8x8 mm) were irradiated with 10 or 40 Gy, and blood and skin samples were collected at 24 and 96 hours post-irradiation. Serum levels of pro-inflammatory cytokines known to be induced by radiation or to mediate the bystander effect, were measured. In parallel, gene expression was measured in irradiated and non-irradiated skin using real time PCR. Statistically significant changes were identified for known radiation responsive genes in both targeted and non-targeted dermal tissue after both BB and MRT treatments. Down-regulation of some genes in distant skin that were up-regulated at the site of irradiation were identified in an apparent contrasting response between these two sets of tissues. Also, the expression for some genes showed differences between MRT and BB-treated mice. MRT-specific bystander responses were also observed in distant tissue, including gene expression of TP53 for which the protein product has a fundamental role in cell fate. Levels of various cytokines in the serum were also altered in response to both BB and MRT. In some cases, the cytokine response was different for MRT compared to BB-treated samples which could potentially explain the benefits of MRT. These results advance the understanding of the biological responses to synchrotron-generated radiation and provide a potential mechanism for MRT.